Abstract
Background
Peritoneal dialysis (PD) patients are advised to restrict sodium intake. For best use of resources, rapid screening tools are required for dietary assessments to allow for targeting of patients. We wished to evaluate the usefulness of food frequency questionnaires (FFQ) for estimating dietary sodium.
Methods
Sodium intake was estimated using the Derby Salt Questionnaire (DSQ), and Royal Free Sodium Questionnaire (RFSQ). Body composition was determined by bioimpedance.
Results
90 peritoneal dialysis patients, 52 men (57.8%), mean age 62 ± 15.8 years, were asked to complete the DSQ and RFSQ questionnaires. 88 completed one or more questionnaire, with 87 completing the DSQ and 86 the RFSQ. The median estimated dietary sodium intake 104 (72–145) mmol/day (2.39 (1.64–3.34) g sodium/day) DSQ, and 92 (60–114) mmol/day (2.11 (1.38–2.62) g sodium/day) RFSQ. Younger patients, aged ≤52 years had greater dietary sodium intake compared to those ≥76 years (RFSQ 105.4 (73–129) vs 96 (71–116) mmol/day), p < 0.05. Extracellular water to total body water (ECW/TBW) was greater in those with higher DSQ estimated dietary sodium intake (0.40 ± 0.01 vs 0.39 ± 0.01, p < 0.05). A multivariable model showed that increased dietary sodium intake was independently associated with increased SMM (DSQ odds ratio (OR) 1.17 (95% confidence limits 1.05–1.32, RFSQ OR 1.15 (1.04–1.27, p < 0.05) and raised ECW/TBW (DSQ OR 1.88 (1.22–2.92) p = 0.004, and ECW/height (RFSQ OR 1.42 (1.02–1.98) p = 0.04.
Conclusions
Both questionnaires were acceptable to patients, and the majority were found to be consuming more dietary sodium than recommended. Dietary sodium estimation was associated with SMM and increased ECW.
Similar content being viewed by others
References
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, DASH-Sodium Collaborative Research Group. et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.
Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int. 2009;29:297–302.
Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant. 2009;24:956–62.
Wileman V, Chilcot J, Armitage CJ, Farrington K, Wellsted DM, Norton S, et al. Evidence of improved fluid management in patients receiving haemodialysis following a self-affirmation theory based intervention: a randomised controlled trial. Psychol Health. 2015;6:1–27.
Tomson CR. Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time. Nephrol Dial Transplant. 2001;16:1538–42.
Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22Suppl 2:ii45–87.
Kutlugün AA, Arıcı M, Yıldırım T, Turgut D, Yılmaz R, Altındal M, et al. Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Nephron Clin Pract. 2011;118:c361–6.
Luis D, Zlatkis K, Comenge B, García Z, Navarro JF, Lorenzo V, et al. Dietary quality and adherence to dietary recommendations in patients undergoing hemodialysis. J Ren Nutr. 2016;26:190–5.
Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Willingham FC, et al. Demographic associations of high estimated sodium intake and frequency of and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England. J Ren Nutr. 2014;24:236–42.
Mason B, Ross L, Gill E, Healy H, Juffs P, Kark A. Development and validation of a dietary screening tool for high sodium consumption in Australian renal patients. J Ren Nutr. 2014;24:123–34.e1-3.
Ekbal NJ, Consalus A, Persaund J, Davenport A. Reliability of delivered dialysate sodium concentration. Hemodial Int. 2016;20(Suppl 1):S2–6.
Inal S, Erten Y, Tek N, Ulusal Okyay G, Öneç K, Akbulut G, et al. The effect of dietary salt restriction on hypertension in peritoneal dialysis patients. Turk J Med Sci. 2014;44:814–9.
Gkza A, Davenport A. Estimated dietary sodium intake in haemodialysis patients using food frequency questionnaires. Clin Kidney J. 2017;10:715–20.
NKF-K/DOQI. Clinical practice guidelines for peritoneal dialysis adequacy: clinical practice recommendations for peritoneal dialysis adequacy. Am J Kid Dis. 2006;48(Suppl 1):S98–S158.
Davenport A. Does peritoneal dialysate affect body composition assessments using multi-frequency bioimpedance in peritoneal dialysis patients? Eur J Clin Nutr. 2013;67:223–5.
Fürstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis. 2011;57:123–9.
Persaud J, Thomas M, Davenport A. Indirect ion selective electrode methods potentially overestimate peritoneal dialysate sodium losses. Ther Apher Dial. 2014;18:321–5.
Fan S, Davenport A. The importance of overhydration in determining peritoneal dialysis technique failure and patient survival in anuric patients. Int J Artif Organs. 2015;38:575–9.
Davenport A. Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract. 2006;104:120–5.
Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant. 1998;13:552–3.
Shah A, Davenport A. Does a reduction in dialysate sodium improve blood pressure control in haemodialysis patients? Nephrol (Carlton). 2012;17:358–63.
Rutkowski B, Tam P, van der Sande FM, Vychytil A, Schwenger V, Himmele R, Low Sodium Balance Study Group. et al. Low-sodium versus standard-sodium peritoneal dialysis solution in hypertensive patients: a randomized controlled trial. Am J Kidney Dis. 2016;67:753–61.
Beto JA, Bansal VK. Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. J Am Diet Assoc. 2004;104:404–9.
Morey B, Walker R, Davenport A. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract. 2008;109:c173–80.
Ross L, Chong SH, Mason B, Healy H. Development and evaluation of a scored sodium questionnaire-screening form for kidney disease patients. J Ren Nutr. 2016;26:159–67.
Dong J, Li Y, Yang Z, Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol. 2010;5:240–7.
Dong J, Li Y, Yang Z, Luo J, Zuo L. Time-dependent associations between total sodium removal and mortality in patients on peritoneal dialysis. Perit Dial Int. 2011;31:412–21.
Fürstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis. 2011;57:123–6.
Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int. 2014;86:489–96.
Yoowannakul S, Davenport A Estimation of lean body mass by creatinine kinetics increases the prevalence of muscle wasting in peritoneal dialysis patients compared to bioimpedance. Eur J Clin Nutr. 2018. https://doi.org/10.1038/s41430-017-0072-z PMID: 29330530
Davenport A. Interdialytic weight gain in diabetic haemodialysis patients and diabetic control as assessed by glycated haemoglobin. Nephron Clin Pract. 2009;113:c33–7.
Udo A, Goodlad C, Davenport A. Impact of diabetes on extracellular volume status in patients initiating peritoneal dialysis. Am J Nephrol. 2017;46:18–25.
Kopp C, Linz P, Maier C, Wabel P, Hammon M, Nagel AM, et al. Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by 23Na magnetic resonance imaging. Kidney Int. 2018. https://doi.org/10.1016/j.kint.2017.11.021.. pii: S0085-2538(17)30857-8PMID: 29455909
Paniagua R, Amato D, Vonesh E, Correa–Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13:1307–20.
Davies SJ. Do we really know the meaning of sodium removal? Perit Dial Int. 2011;31:383–6.
Acknowledgements
Dr. B Caplin for statistical advice.
Funding
Royal Free Hospital and University College London.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Amalia, R.I., Davenport, A. Estimated dietary sodium intake in peritoneal dialysis patients using food frequency questionnaires and total urinary and peritoneal sodium losses and assessment of extracellular volumes. Eur J Clin Nutr 73, 105–111 (2019). https://doi.org/10.1038/s41430-018-0259-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-018-0259-y
- Springer Nature Limited
This article is cited by
-
Does using a higher dialysate sodium concentration result in lower sodium losses with dialysis treatments?
Renal Replacement Therapy (2024)
-
Frailty, appendicular lean mass, osteoporosis and osteosarcopenia in peritoneal dialysis patients
Journal of Nephrology (2022)
-
Factors associated with systolic hypertension in peritoneal dialysis patients
Journal of Nephrology (2020)